Skip to content
10-Q

Quarterly Report

Arno Therapeutics, Inc

0001144204-14-068764

← back to feed
Filed
Nov 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Nov 14, 2014 20.41M sh
Stockholders Equity Q3 2014 · Sep 30, 2014 −$6.17M
Stockholders Equity Q3 2014 · Dec 31, 2013 −$12.88M
Current Liabilities Q3 2014 · Sep 30, 2014 $2.87M
Current Liabilities Q3 2014 · Dec 31, 2013 $3.9M
Total Liabilities Q3 2014 · Sep 30, 2014 $17.96M
Total Liabilities Q3 2014 · Dec 31, 2013 $39.77M
Current Assets Q3 2014 · Sep 30, 2014 $11.75M
Current Assets Q3 2014 · Dec 31, 2013 $26.86M
Total Assets Q3 2014 · Sep 30, 2014 $11.79M
Total Assets Q3 2014 · Dec 31, 2013 $26.88M
Shares Diluted Q3 2014 · Sep 30, 2013 4.93M sh
Shares Diluted Q3 2014 · Sep 30, 2013 4.77M sh
Capex Q3 2014 · Sep 30, 2013 $0
Cash And Equivalents Q3 2014 · Sep 30, 2013 $1.54M
Cash And Equivalents Q3 2014 · Dec 31, 2012 $10.94M
Eps Diluted Q3 2014 · Sep 30, 2013 −$0.75
Eps Diluted Q3 2014 · Sep 30, 2013 −$3.34
Eps Basic Q3 2014 · Sep 30, 2013 −$0.75
Eps Basic Q3 2014 · Sep 30, 2013 −$3.34
Sga Expense Q3 2014 · Sep 30, 2013 $617.83K
Sga Expense Q3 2014 · Sep 30, 2013 $2.14M
Rd Expense Q3 2014 · Sep 30, 2013 $3.17M
Rd Expense Q3 2014 · Sep 30, 2013 $8.9M
Net Income Q3 2014 · Sep 30, 2013 −$3.68M
Net Income Q3 2014 · Sep 30, 2013 −$15.92M
Operating Income Q3 2014 · Sep 30, 2013 −$3.79M
Operating Income Q3 2014 · Sep 30, 2013 −$11.04M